Taking people in SpainPhase 1
Tests VVD130037 in adults with advanced solid tumors and lung cancer
Tests the drug VVD130037 in adults with advanced solid tumors, including squamous lung cancer.
Plain-language title generated from the registry record
Registry title: A Phase 1, Open-Label, Multicenter, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-Tumor Activity of VVD130037, in Participants With Advanced Solid Tumors
Key facts
- Where
- Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, and Valencia, SpainSee the 11 sites
- Phase
- Phase 1
Where in Spain
- Hospital HM Nou DelfosBarcelona, SpainTaking people
- Hospital Universitari Dexeus Grupo QuironsaludBarcelona, SpainTaking people
- Hospital Universitari Vall d'HebronBarcelona, SpainTaking people
- Hospital General Universitario Gregorio MarañónMadrid, SpainTaking people
- Hospital Universitario 12 de OctubreMadrid, SpainTaking people
- Hospital Universitario Fundación Jiménez DíazMadrid, SpainTaking people
- Hospital Universitario HM SanchinarroMadrid, SpainTaking people
- Hospital Universitario Ramón y CajalMadrid, SpainTaking people
- Clínica Universidad de navarraPamplona, SpainTaking people
- Hospital Universitario Quironsalud MadridPozuelo de Alarcón, SpainTaking people
- Hospital Clinico Universitario de ValenciaValencia, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vividion Therapeutics Inc.
- Trial code
- NCT05954312EU 2023-506199-28-00
- Record updated
- 20 August 2026